| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.17 | 0.3 |